• Advise clients, including in-house general counsel, research and development teams, and business partners of companies in the pharma and biotech industries, in developing and implementing a strategic vision for the companies’ global intellectual property portfolio.• Contribute to the achievement of companies’ growth objectives by developing an in-depth understanding of their business model, products, technology, and challenges to provide sound strategic advice and insights.• Serve as a key strategic partner in providing relevant advice, guidance and leadership throughout the product development and commercialization process.• Collaborate with company’s business leaders and in-house counsel to execute complex global commercial IP transactions including assisting with deal structuring, drafting legal documents, and carrying out negotiations, in addition to providing support in IP disputes and litigation matters.• Educate inventors and company executives in identifying opportunities for patent protection, developing, advocating, and implementing IP protection policies, and licensing and commercialization opportunities.

• Assisted clients in global patent portfolio management, including application drafting, prosecution, and innovation development.• Drafted freedom to operate, invalidity, and non-infringement opinions, including conducting due diligence, patentability, and freedom-to-operate searches, and drafting relevant reports.• Prepared, filed, and prosecuted trademark applications, including conducting trademark searches, and preparing clearance reports, in addition to assisting senior attorneys with copyright and trade secret matters.• Supported the Firm’s litigation team in Hatch-Waxman, Biosimilars and Trademark litigation matters, in addition to assisting the Firm’s transactional team in IP-related transactional matters, including MTAs, CDAs, research collaborations and license agreements.• Generated leads, including proposing marketing strategy ideas to optimize targeting of clients, performing competitive analysis and company branding to increase exposure of the team and the Firm for client recruitment.• Spearheaded Firm Symposium to recruit companies involved in Abbreviated New Drug Application (ANDA) filings. 09/15-09/16 - Fanelli Haag PLLC, which merged with Seyfarth Shaw LLP as of October 1st, 2016. "http://www.seyfarth.com/news/fanellihaag-joins-seyfarth"

• Managed patent prosecution docket with over 200 applications, worldwide, from various U.S. and foreign based biotech companies and foreign law firms in the fields of antibody engineering and therapeutics, pharmaceuticals, molecular diagnostics, cancer immunology, nanotechnology, chemistry (organic and inorganic), medical devices, and other non-life science related fields such as nuclear reactors, biofuels, fire arms, and construction material.• Assisted clients in developing intellectual property strategies and portfolios, including communicating with inventors and/or corporate officers regarding the product of interest and available budget, and recommending strategies for future research and development.• Drafted non-infringement, invalidity and freedom to operate opinions in the fields of antibody and cancer therapeutics, pharmaceuticals, molecular diagnostics, nanotechnology, and medical devices.• Provided investment companies an informed evaluation of the value and risks presented by the target company by conducting due diligence, including providing a detailed investigative report containing portfolio strategy/counseling, and a comprehensive understanding of intellectual property assets.

• Maintained a prosecution docket with over 250 applications in more than 50 countries, including preparing, filing, and prosecuting patent applications in diverse technological fields related to plant science, antibody engineering and therapeutics, cancer immunology, pharmaceuticals, vaccines, medical devices, polymer chemistry, biomaterial, and biofuels.• Counseled clients, including big pharma and startup biotech companies, in strategically directing research and development towards open spaces in the field.• Assisted in patent litigation, including drafting non-infringement, freedom to operate and invalidity opinions.04/08 - 10/08: Connolly Bove Lodge & Hutz LLP, moved to Womble Carlyle with the entire team from Connolly Bove in October 2008. "http://www.lexmundi.com/NewsBot.asp?MODE=VIEW&ID=1333"

• Scrutinized patent applications for patentable subject matter, novelty, non-obviousness, written description, indefiniteness, and enablement, including assessing the applications for their compliance with basic format, rules and legal requirements.• Conducted detailed examination of patent applications, prepared reports and made final decisions as to the novelty of the invention; and discussed and negotiated with the applicants’ representatives to resolve matters regarding patentability.

• Identified and analyzed chemotherapeutic drugs that activate various human herpes virus-8 (HHV-8) in infected cells, and characterized the effects of such drug combinations in hypoxic conditions.• Tested and developed new chemical entities suitable for therapeutic use in human immunodeficiency virus (HIV) and HHV-8 infected individuals.

• Manufactured hydrocell high-performance liquid chromatography (HPLC) columns for biomolecule separation.